Marker Therapeutics, Inc. rose 11.3% on Monday, November 9, 2026, on 231,449 shares. No headline about MRKR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Marker Therapeutics, Inc. (MRKR:NASDAQ) closed at $0.950 on November 10, 2026, down 4.05% on the day. The stock trades 61.4% below its 52-week high of $2.46 and 9.2% above its 52-week low of $0.870. Over the past year, it gained 2.1%. Marker Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 10, 2025, MRKR closed higher on 111 days (44%). Its best day was April 9, 2026 (+19.86%) and its worst was January 26, 2026 (-10.95%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 1 time.
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Find more stocks like MRKR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.